ICMR has licensed a cervical cancer drug candidate to Emcure and two vaccine technologies to Biological E to accelerate affordable healthcare innovations.

ICMR has licensed a cervical cancer drug candidate to Emcure and two vaccine technologies to Biological E to accelerate affordable healthcare innovations.

The Indian Council of Medical Research has licensed three new biomedical technologies. These innovations aim to advance cancer treatment and infectious disease protection. One…